Amputation Avoided: How PRF Saved a Finger in a Severe CREST Syndrome Case
When treating patients with autoimmune conditions, clinical management can easily become a race against time. Conventional methods do not always succeed, and in this case, the surgical debridement and treatment using antibiotics by dermatologists failed to help this patient.
Featured Top-Ranked Publication: Use of PRF for the treatment of CREST syndrome: A Case Report
Co-Author Spotlight: Bridging Global Research & Clinical Practice
This clinical milestone was achieved by Dr. Ryan Goslin, FAGD (Private Practice, Williston, Vermont, USA): An exceptional clinical practitioner, Dr. Goslin brought this advanced scientific protocol directly to the chairside. A lifelong student of medicine and dentistry, he holds a Fellowship with the Academy of General Dentistry (FAGD), a distinction earned by only about 6% of general dentists. He is also a Fellow of the International Congress of Oral Implantologists (ICOI), holds a background as a Registered Dietitian from Brigham and Women's Hospital, and served in the United States Navy.
The Challenge: A 6-Month Stalemate
A 35-year-old female patient with CREST syndrome presented with a significant 1.5cm round open wound on her right index finger following an accidental cut with hairdresser scissors. Due to the disease's characteristically excessive collagen buildup and drastically reduced blood flow in the digits, localized wound management is heavily compromised.
For six months, conventional dermatological interventions, including multiple attempts at surgical debridement and various antibiotic courses, completely failed. The wound steadily deteriorated, displaying visible necrotic tissue, throbbing pain, and purulence at the margins. With no signs of healing, a formal medical recommendation for digital amputation was made.
The Intervention: Deploying PRF
While the patient was not prepared to undergo amputation, we stepped in with a novel solution. PRF was utilized based on established literature demonstrating its powerful ability to revascularize tissue, promote soft tissue wound healing, and enhance epithelialization.
Following written informed consent, we initiated an intensive 45-day treatment protocol:
Dual-Action Delivery: Utilizing the Bio-PRF system and optimized horizontal centrifugation (700 RCF for 8 minutes) , the protocol combined targeted liquid-PRF injections around the periphery and base of the defect alongside the topical application of two solid PRF membranes.
Frequency: The exact procedure was repeated every 3 days for a total of 15 treatments.
The Outcome: Week by week, the defect progressively shrunk. By day 45, the wound achieved complete resolution. At a 15-month medical follow-up, the finger morphology had returned entirely to its normal structure with 100% normal sensation and zero pain.
Why This Matters for Your Practice
Whether you are a dermatologist treating refractory skin ulcers, a dentist managing compromised oral mucosa, or a physician treating ischemic extremities, this case highlights two profound physiological advantages of PRF:
Angiogenesis: PRF heavily drives neovascularization and supports soft tissue regeneration, directly overcoming the primary limitations of localized ischemia seen in conditions like Raynaud's phenomenon.
Antimicrobial & Analgesic Protection: Beyond tissue growth, PRF naturally exerts sustained antimicrobial properties against wound pathogens while significantly mitigating patient pain throughout the healing cycle.
As we continue to observe in the data, not all APCs are created equal. Moving away from traditional PRP anticoagulants and utilizing optimized horizontal centrifugation unlocks a biomaterial capable of completely turning the tide on cases previously deemed untreatable.
Miron Message | Bringing the global standard of regenerative medicine into daily practice
Dr. Richard Miron
Comments